VESLOR

Details for Australian Trade Mark No. 1091975 (hide)

Owner Encysive Pharmaceuticals Inc. a Delaware corporation

Convention US 14 December 2005 76652182

Service Spruson & Ferguson

Various Convention priority is based on United States trade mark application no. 76652182 dated 14 December 2005 for PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF HEART FAILURE, ESSENTIAL HYPERTENSION, PROSTATE CANCER, PULMONARY HYPERTENSION, SUBARACHNOID HEMOR

Filing Date 20 December 2005

Classes

Class 5 Pharmaceutical preparations for human use including pharmaceuticals for the treatment of heart failure, essential hypertension, prostate cancer, pulmonary hypertension, subarachnoid hermorrhage, asthma, psoriasis and organ reperfusion injury

Event Publications

19 January 2006 Application filed

13 April 2006 Application Accepted

10 August 2006 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1091976-PRESELA

1091974-POWER ARCHITECTURE